Prot #SARC041: Phase 3 Randomized Double-Blind Study of Abemaciclib versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma

Project: Research project

Project Details

StatusActive
Effective start/end date12/2/21 → 12/2/27

Funding

  • SARC ((OE) Prot #SARC041 // (OE) Prot #SARC041)
  • Lilly USA, LLC ((OE) Prot #SARC041 // (OE) Prot #SARC041)